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DockStream: a docking wrapper to enhance 
de novo molecular design
Jeff Guo1, Jon Paul Janet2, Matthias R. Bauer3, Eva Nittinger4, Kathryn A. Giblin5, Kostas Papadopoulos1, 
Alexey Voronov1, Atanas Patronov1, Ola Engkvist1,6 and Christian Margreitter1*  
Abstract 
Recently, we have released the de novo design platform REINVENT in version 2.0. This improved and extended itera-
tion supports far more features and scoring function components, which allows bespoke and tailor-made protocols 
to maximize impact in small molecule drug discovery projects. A major obstacle of generative models is producing 
active compounds, in which predictive (QSAR) models have been applied to enrich target activity. However, QSAR 
models are inherently limited by their applicability domains. To overcome these limitations, we introduce a structure-
based scoring component for REINVENT. DockStream is a flexible, stand-alone molecular docking wrapper that 
provides access to a collection of ligand embedders and docking backends. Using the benchmarking and analysis 
workflow provided in DockStream, execution and subsequent analysis of a variety of docking configurations can be 
automated. Docking algorithms vary greatly in performance depending on the target and the benchmarking and 
analysis workflow provides a streamlined solution to identifying productive docking configurations. We show that an 
informative docking configuration can inform the REINVENT agent to optimize towards improving docking scores 
using public data. With docking activated, REINVENT is able to retain key interactions in the binding site, discard 
molecules which do not fit the binding cavity, harness unused (sub-)pockets, and improve overall performance in the 
scaffold-hopping scenario. The code is freely available at https:// github. com/ Molec ularAI/ DockS tream.
Keywords: De novo design, Generative Models, Reinforcement Learning (RL), Molecular docking, Structure-based 
drug discovery (SBDD)
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Introduction
Machine learning has emerged as a versatile tool with 
potential to accelerate drug discovery. One of the quin-
tessential problems is de novo drug design which 
involves finding promising candidate molecules that sat-
isfy a multi-parameter optimization (MPO) objective. 
[1, 2] The major obstacle is the sheer number of possible 
molecules, estimated to be on the order of 10 10^60 [23–
60], effectively preventing a brute-force search of chemi-
cal space. [3] Recently, generative models have been 
proposed to sample chemical space beyond what is cov-
ered by established datasets by conferring the ability to 
sample novel compounds. Neural network architectures 
including recurrent neural networks (RNNs), variational 
autoencoders (VAEs), generative adversarial networks 
(GANs), and graph neural networks (GNNs) have dem-
onstrated success in using input data as SMILES or 
molecular graphs to generate promising chemical ideas 
[2, 4–7]. Moreover, reinforcement learning (RL) has been 
applied in conjunction with generative models to apply 
an iterative design process in which an agent (a model) 
learns to generate compounds achieving increasing 
scores.
over time [4, 8, 9] RL encourages the agent to make 
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can be tailored to optimize drug-like properties. The 
synergistic application of generative models and RL has 
demonstrated potential for de novo drug design by pro-
viding a solution to MPO and notably mitigating the 
computational burden of a brute-force search of chemi-
cal space. This approach is also very versatile in terms of 
components that can be optimized. Notably, quantitative 
structure–activity relationship (QSAR) models have been 
applied to great effect to enrich target activity [10]. How-
ever, such models are limited in their generalizability and 
thus often restricted to relatively small domains of appli-
cability which hinders the ability to sample truly novel 
compounds [11, 12].
On the other hand, existing physics-based methods 
such as molecular docking continues to be an invaluable 
tool to identify molecules that are promising drug can-
didates [13–16]. The advent of high-performance com-
puting (HPC) has enabled in silico virtual screening (VS) 
to consider increasingly larger datasets. This enhanced 
capability has seen success in identifying more hits with 
diverse chemotypes and scaffolds, often desirable in 
structure-based drug discovery (SBDD) [16]. VS typically 
screens molecular libraries whose compounds are readily 
available, offering the potential to expedite experimenta-
tion. However, chemical ideas are inherently restricted to 
the pre-defined chemical space of these collections which 
may not satisfy the rigorous criteria in a project. Instead, 
VS is often used to steer human creativity to a relevant 
chemical sub-space where iterative design discovers the 
final drug compound. While strategies such as screening 
privileged scaffolds can narrow the search space, compu-
tational costs of in silico docking rapidly becomes pro-
hibitive and resources may be sub-optimally allocated 
towards exploring unproductive chemical space [17]. 
Thus, efficient traversal of chemical space remains a non-
trivial endeavour.
More recently, molecular docking has been incorpo-
rated into RL generative model paradigms, offering a 
proposed solution that integrates structural information, 
steering molecular design by rewarding compounds that 
exhibit good docking scores and circumventing some 
limitations of QSAR models. [18–21] However, it is often 
challenging to ascertain what exactly constitutes a ‘good’ 
docking score. Docking algorithms are inherently sensi-
tive to the three-dimensional (3D) representation of the 
protein and ligands [22, 23]. Moreover, different docking 
configurations may be better suited for particular tar-
gets, and performance is intricately dependent on ligand 
embeddings to sample sufficiently many conformations 
to access a binding pose deemed favourable. Conse-
quently, while docking scores are a proxy for binding free 
energies, an accurate prediction is beyond the capability 
of docking algorithms, caused to a large extent by a lack 
of sampling of the receptor dynamics and insufficient 
treatment of entropic effects [24, 25]. Thus, in RL scenar-
ios where docking is a component of the reward function, 
a poor choice of the docking algorithm or the docking 
score reward can accentuate the limitations of docking 
and misinform the agent.
Herein, we introduce DockStream, a molecular docking 
wrapper providing a unified interface to access a collec-
tion of ligand embedders and docking backends. Dock-
Stream provides an automated and streamlined platform 
to run docking experiments, supporting a large variety of 
possible configurations. Automated analysis of docking 
results expedites search for a docking configuration that 
performs best for the specific target and set of ligands—
i.e. one that displays good correlation with experimental 
binding affinity or potency. The use of DockStream as a 
stand-alone tool for SBDD is demonstrated by bench-
marking the DEKOIS 2.0 dataset which curates 81 tar-
gets with provided sets of active and decoy ligands [26]. 
The flexibility of DockStream to specify different docking 
configurations facilitates tailored protocols for different 
end applications as docking performance necessarily var-
ies depending on the target system. Subsequently, Dock-
Stream is integrated with REINVENT 2.0, the recently 
published de novo design platform [4]. Docking provides 
structural information to the REINVENT agent, facilitat-
ing docking score optimization via RL and steering explo-
ration to relevant chemical space. Using DockStream 
as a scoring function component enables REINVENT 
to design compounds that retain key interactions in the 




DockStream is a molecular docking wrapper providing 
access to a collection of ligand embedders: Corina, Lig-
Prep, OMEGA, and RDKit, and docking backends: Auto-
Dock Vina, Glide, GOLD, Hybrid, and rDock (Fig.  1) 
[27–41]. DockStream streamlines molecular docking by 
handling all necessary steps under a unified platform: tar-
get preparation, ligand embedding, and docking. Target 
preparation usually starts with refining a protein crys-
tal structure, often involving adding missing hydrogen 
atoms, defining side chain ionization and tautomeric 
states, and minimizing the conformational energy [42]. 
The final orientation of amino acid residues around a ref-
erence ligand defines the binding cavity and the docking 
search space. Ligand embedding refers to the generation 
of 3D molecular configurations for the ligands that are to 
be docked, thus defining an initial ligand conformational 
state that can affect docking search space traversal [23]. 
By enumerating tautomeric states and stereoisomers, 
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this stage can also lead to an expansion of the ligand set. 
Finally, docking itself adheres to specified parameters 
that control the rigor of a conformational search to gen-
erate so-called binding poses and scores that are typically 
used to inform SBDD. All of these preparatory steps must 
be considered in tandem to identify a useful docking con-
figuration. DockStream provides numerous solutions to 
each component required for molecular docking via the 
supported backends whose parameters can be controlled 
by a single input JSON. The flexibility of the parameter 
definitions lends itself to applicability across diverse 
docking problems. Beyond providing access to a variety 
of backends, notable features of DockStream include:
1. Ligand tautomer/stereoisomer handling providing a 
thorough enumeration of atom spatial arrangements 
and states.
2. Different write-out modes to output poses and scores 
corresponding to either the best per ligand (and all 
its enumerations), best per enumeration (each tau-
tomer/stereoisomer generated), or all ligand enumer-
ations.
3. Parallelization across cores to speed-up execution 
(see Additional file 1: Fig. S1).
An example LigPrep configuration in an input JSON 
is shown below (see Additional file 1 for an example full 
input JSON that includes docking) [30]:
Fig. 1 Overview of DockStream platform providing access to a variety of docking backends. Target preparation, ligand embedding, and docking 
are handled in the unified platform. The docking scores and poses are outputted
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Notable settings include:
1. The “parallelization” block specifies to parallelize Lig-
Prep over 4 CPU cores, distributing a maximum of 1 
compound per core at a time.
2. The “use_epik” block provides access to LigPrep 
capabilities including specifying a desired pH and a 
pH tolerance.
3. The “force_field” block allows one to specify the 
desired force field which may be particularly relevant 
when reproducing previous docking experiments.
4. The “input” block specifies the input path for the 
SMILES to be embedded by LigPrep.
5. The “output” block is optional and specifies the 
desired output directory for the embedded ligands.
Once an input JSON is constructed, DockStream can 
be excecuted via the command line:
python docker.py -conf < path to input JSON > 
Docking evaluation
The suitability of an in silico docking configuration is 
usually assessed by its sampling or scoring power [23]. 
The former refers to the ability to reproduce binding 
poses of reference ligand-receptor co-crystal structures, 
often measured by the root-mean-square deviation 
(RMSD) of the atomic coordinates. The latter refers to 
the ability to rank binding affinities based on the dock-
ing score. In the ideal scenario, the docking configuration 
displays excellent sampling and scoring power, but this is 
typically not observed. Rather, docking algorithms may 
be better suited for either task where choice of a docking 
configuration will be dependent on the desired use case 
[39, 43]. In practice, finding an informative docking con-
figuration is challenging owing to the inherent sensitivity 
of scoring functions to the 3D representation of proteins 
and ligands. DockStream expedites this search by auto-
mating the execution and analysis of molecular docking 
experiments via the benchmarking and analysis scripts, 
respectively (Fig. 2).
Benchmarking
Using DockStream, a single input JSON file defines all 
parameters required for a molecular docking experi-
ment. Modifying parameters in the JSON defines a new 
docking configuration and offers complete flexibility 
in executing all supported backends. The benchmark-
ing script in turn takes as input an arbitrary number of 
configuration JSONs, and executes all defined docking 
experiments sequentially, returning the docked poses and 
scores (Fig.  2). Analysis of resulting docking scores can 
be automated by the analysis script which supports three 
modes (see Additional file  1 for details regarding each 
mode):
1. Enrichment analysis to evaluate whether a docking 
configuration scores active ligands better than decoys 
(on average).
2. Correlation analysis to evaluate how well, if at all, the 
docking scores correlate with experimental results.
3. Thresholds analysis to probe the distribution of 
docking scores and experimental results given a set 
of defined thresholds that serve as a hard boundary 
between classification as active or inactive. This func-
tionality is well suited to investigate general separa-
tion of data points in cases where poor correlation 
between docking scores and experimental results is 
observed.
Similar to docking, a single input JSON defines all 
parameters required for the analysis script. Moreover, 
all analysis modes take as input an arbitrary number of 
docking outputs. Therefore, the DockStream benchmark-
ing and analysis scripts workflow is pertinent to expedite 
search for a docking configuration well suited for various 
SBDD applications.
Enrichment analysis
The ability of a docking configuration to distinguish 
between active and decoy ligands is useful for hit dis-
covery where the goal is to identify a sufficiently active 
ligand against a target. The logarithmic receiver operat-
ing characteristic (pROC) area under the curve (AUC) 
is calculated and provides a measure of enrichment. The 
logarithmic transform of the classical ROC curve biases 
the contributions to the AUC towards early actives recov-
ered and is therefore particularly advantageous for evalu-
ating early enrichment [44]. The pROC AUC is given by 
Eq. 1:
where n is the total number of active and decoy ligands 
and βi is the false positive rate (FPR) for when the i th 
active is recovered in the ordered (by docking score) list. 
A greater pROC AUC value demonstrates enrichment 
and is attributed to the ability of a docking configuration 
to distinguish between actives and decoys. The pROC 
AUC expected for random selection is 0.434 (in contrast 
to 0.5 for the classical ROC AUC). Importantly, unlike 
the ROC AUC that enforces an upper bound of 1.0, the 
pROC AUC is formally unbounded. In practice, however, 
it is constrained by the relative frequency of recovering 
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Fig. 2 DockStream automated molecular docking workflow via the benchmarking and analysis scripts. Each configuration JSON file specifies all 
the parameters required for a docking experiment. The analysis script supports 3 analysis modes: Enrichment, Correlation, and Thresholds (see 
Additional file 1 for details)
Correlation analysis
In lead optimization, one may be interested in increas-
ing potency. Docking scores are often used as a crude 
proxy for binding free energies and thus, it would be 
straightforward to simply consider compounds exhibit-
ing good scores. However, accurate prediction of binding 
free energies is often beyond the scope of these scoring 
functions and there is no guarantee the aforementioned 
approach will yield novel leads with enhanced potency 
[24, 25]. Instead, identifying a docking configuration 
that displays good correlation between docking scores 
and experimental binding affinities for a calibration set 
can guide iterative lead compound selection and bolster 
confidence in the results. The Spearman (ρ) ∈ [−1, 1] and 
Kendall Tau-b ( τB) ∈ [−1, 1] rank correlation coefficients 
provide a quantitative measure between ordinal variables 
[45, 46]. The Spearman correlation is given in Eq. 2:
where n is the total number of ligands and di is the dif-
ference between the ranks of the i th docking score and 
experimental binding affinity. If the docking scores and 
experimental binding affinities are perfectly monotonic 
with respect to each other, then ρ = 1 (see Additional 















(C + D + Tdock) ∗
(
C + D + Texp
)
where C and D are concordant and discordant pairs, 
respectively, and Tdock and Texp are the number of ties in 
the docking scores and experimental binding affinities 
data, respectively. Similar to Spearman, if the data is per-
fectly monotonic with respect to each other, then τB = 1 . 
An important distinction between Spearman and Kendall 
is that the latter accounts for ties in the data [46]. This is 
particularly relevant in binding assays where compound 
activities may exceed the limit of quantification (LOQ). 
Consequently, these compounds are assigned the value at 
the limit, resulting in ties in the data. In general, Kendall 
is a more informative measure than Spearman in these 
cases.
REINVENT overview
REINVENT is a de novo design platform that uses gen-
erative models to sample compounds in SMILES format. 
[4, 47] SMILES generation is formulated as a natural 
language processing (NLP) problem whereby atoms are 
tokenized into machine-readable vocabulary. Compound 
SMILES are then generated token by token based on 
sequential conditional probabilities, analogous to a typi-
cal NLP problem. The underlying architecture of REIN-
VENT uses RNNs and is based on work by Arús-Pous 
et al. [48]. The specific architecture used in this work is 
a RNN with embedding size 256, three hidden layers of 
512 gated recurrent unit (GRU) cells, and a linear layer 
with softmax activation [49]. Model training followed 
two steps: first, a prior generative model was trained on 
the ChEMBL dataset [50]. The agent policy was initial-
ized based on the prior before diverging into individual 
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experiments. The RL was conducted for 1000 epochs, 
thus iteratively calibrating the agent’s likelihood of sam-
pling desirable compounds (see Additional file  1 for 
details).
Scoring function
The scoring function, S(x) ∈ [0, 1] offers complete flex-
ibility in the defined properties to optimize, including 
topological polar surface area (TPSA), molecular weight 
(MW), number of hydrogen bond donors (HBD), molec-
ular docking score, and custom QSAR models. In this 
work, S(x) is formulated as a weighted geometric mean 
given in Eq. 4:
where n is the number of properties, Pi(x)wi is the score 
calculated for the i th property for the sampled com-
pound, and wi is the weighting for the i th property. 
Properties assigned a greater weighting contribute more 
significantly to S(x) and the weighted geometric mean 
necessitates every property to be reasonably satisfied. 
Otherwise, the total score diminishes eliciting negligible 
change during agent feedback. In this work, all properties 
were assigned a weighting of 1, denoting equal impor-
tance. Greater weightings such as 5 or 10 may be assigned 
to target properties to increase their relative importance 
in the scoring function. For instance, given a lead optimi-
zation task to enhance predicted potency and solubility, 
one could assign a greater weighting to docking and the 
corresponding QSAR model.
Diversity filters (DF)
A consequence of the iterative design cycle is that the 
agent may become stuck in local minima and sample 
increasingly similar compounds so as to exploit a single 
solution found. A diversity filter (DF) is applied to penal-
ize sampled compounds based on the notion of bucket 
saturation (details as in the REINVENT 2.0 paper) [4, 
47]. The topological DF is used in this work which takes 
a compound scaffold and converts all atoms into sp3 car-
bons. Compounds with similar scaffolds that satisfy S(x) 
are stored in buckets with limited size (25 in this work). 
Buckets are filled when such compounds are repeat-
edly sampled. Once full, the next compound with scaf-
fold similarity above a certain threshold will penalize the 
agent to disincentivize further sampling of the scaffold 
and encourage exploration to other chemical space. This 















DockStream can be specified as a component to REIN-
VENT (see Additional file  1: Fig. S15 for more details), 
conferring the ability to incorporate molecular docking 
into S(x) . While it is straightforward to impose dock-
ing score optimization in REINVENT, defining a useful 
docking configuration remains challenging. Ideally, the 
docking score should be biased to either exhibit high 
correlation with experimental activity or at least be able 
to distinguish active and decoy ligands. Similar to using 
DockStream as a stand-alone docking tool, the bench-
marking and analysis workflow (Fig.  2) can be used to 
automate search for such a docking configuration. There 
are two use cases:
1. Enrichment analysis to assess the ability of the dock-
ing configuration to distinguish between active and 
decoy ligands. Here, the range of docking scores for 
active ligands is important to define an appropriate 
transformation function, P ∈ [0, 1] , that normalizes 
the raw score such that it can be integrated into S(x) . 
Ultimately, the agent learns to propose compounds 
that score well using the given docking configuration.
2. Correlation analysis to assess the ability of the dock-
ing configuration to rank compounds relative to their 
experimental activity. Here, higher values for the cor-
relation metrics are desired with attention given to 
experimental assays that artificially restrict the range 
of values due to the LOQ. Compounds that score 
well should have a greater likelihood of being potent 
binders.
Identifying an informative docking configuration 
enhances the quality of the compounds proposed by 
REINVENT. In scaffold hopping scenarios with dock-
ing, sampled compounds are able to retain key interac-
tions while simultaneously exploring new ones. As long 
as the binding pose is similar to that of known binders, 
this approach can guide the agent to produce promis-
ing candidate molecules. Importantly, this can dissuade 
entropically driven binding which is notorious for off-
target activity and toxicity, provided the generated ligand 
maintains similar lipophilic ligand efficiency [52].
Results
DockStream DEKOIS 2.0 evaluation
The use of DockStream as a stand-alone tool was dem-
onstrated by benchmarking the DEKOIS 2.0 dataset 
which curates 81 targets each with 40 actives and 1200 
decoys. The dataset was curated to represent a reasona-
ble fair assessment of docking performance by addressing 
diverse properties, including removal of Pan Assay Inter-
ference Compounds (PAINS) and covalent binders in 
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bioactivity data, ensuring similar physico-chemical prop-
erty matching between actives and decoys, and ensuring 
diverse chemotypes to avoid scaffold bias [26, 53]. The 
overall docking results reproduce and extend the obser-
vations of the original DEKOIS 2.0 benchmarking. The 
5 supported docking backends: AutoDock Vina, GOLD, 
Glide, Hybrid, and rDock were paired with 3 ligand 
embedders: Corina with TautEnum, LigPrep, and RDKit 
with TautEnum to generate 15 distinct docking configu-
rations [27–30, 33–38, 40, 41, 54, 55]. It is important to 
note that each docking configuration has many tunable 
parameters and screening every permutation is infeasi-
ble. Therefore, the default settings were kept with a few 
exceptions (see Methods for details). The benchmarking 
script was used to automate docking using each docking 
configuration for all 81 targets, resulting in 1215 dock-
ing runs and over 1,500,000 ligands docked. The analysis 
script was used to automate enrichment analysis and the 
pROC AUC values are shown in Fig. 3. The pROC AUC 
for a docking configuration that is no better than random 
selection in distinguishing actives and decoys is 0.434. 
Glide led to the most observed enrichment followed by 
Hybrid and GOLD, while the open-source docking back-
ends, AutoDock Vina and rDock yielded less overall 
enrichment. In some cases, AutoDock Vina and GOLD 
failed to dock the entire set of ligands (see “Methods” 
section for details). In general, docking backends are 
not very sensitive to the choice of ligand embedder for 
the DEKOIS 2.0 targets. However, there are cases where 
the ligand embedder does have a significant effect on 
observed enrichment. For instance, AutoDock Vina with 
Corina and TautEnum for BCL2, Hybrid with LigPrep for 
RXRa, and rDock with RDKit and TautEnum for COX2, 
perform best within their ligand embedder series. There-
fore, no single ligand embedder always performs best and 
while screening through n different ligand embedders 
necessitate n docking runs, increases in enrichment may 
identify a valuable docking configuration that otherwise 
would have been overlooked. Furthermore, no single 
docking backend performed best for all targets (compare 
COX2 Glide and AutoDock Vina ACHE for example). 
Alternatively, the goal may be to identify a reasonably 
good docking configuration with the highest through-
put. Hybrid is particularly well suited for this owing to its 
speed and it may be the case that it also performs best or 
close to best performing as observed in the case of KIF11 
and AR, respectively. Naturally, docking varies in perfor-
mance for different target systems and ligand sets. The 
flexibility and ease of specifying different docking con-
figurations and automating their execution and analysis 
demonstrates the value of a tool like DockStream.
REINVENT‑DockStream experiments
REINVENT experiments were performed with Dock-
Stream as a specified component to demonstrate the 
agent can learn to optimize docking scores and hence 
implicitly incorporate 3D structural information. To 
enforce “drug-likeliness”, the MPO problem was defined 
as optimizing the following properties with resemblance 
to Lipinski’s Rule of 5 [56]:
(1) Docking score (docking backend and target specific, 
see Additional file 1: Figs. S17–S33)
(2) Quantitative  Estimate of “Druglikeness” (QED) 
Score ∈ [0, 1] [57]
(3) Number of hydrogen bond donors (HBD) ∈ [0, 7] 
(see Additional file 1: Fig. S16a)
(4) Molecular weight (MW) ∈ [200, 575] (see Addi-
tional file 1: Fig. S16b)
In our experience, enforcing QED optimization made 
the molecular generation process more challenging but 
was necessary for the agent to propose “drug-like” com-
pounds [58]. In the absence of QED, the agent learns 
to exploit the weak spots of docking scoring functions, 
proposing unreasonable molecules with artificially good 
docking scores. Furthermore, a well known phenomenon 
in RL is catastrophic forgetting in which the agent for-
gets previous learnings over the course of training [59]. 
To mitigate this, inception is used which is based on 
experience replay whereby top scoring compounds are 
randomly replayed to the agent during training and is 
implemented as described by Blaschke et al. [4].
REINVENT-DockStream experiments were per-
formed for all 15 backend and ligand embedder combi-
nations used in the DEKOIS 2.0 benchmarking (Fig.  3). 
15 targets were selected (1 for each backend and ligand 
embedder combination) based on exhibiting a pROC 
AUC > 1, indicating actives scoring better than decoys (on 
average) (see Additional file 1: Table S1 for details). The 
rationale was that given the agent learns to optimize the 
docking scores, selecting an appropriate docking score 
transformation will steer the REINVENT agent to pro-
pose compounds that are more likely to be true binders. 
Sampled training plots (1 for each docking backend) for 
the REINVENT-DockStream experiments are shown in 
Fig.  4 (see Additional file  1: Figs. S16–33 for all plots). 
The agent learned to propose compounds with increas-
ingly favourable docking scores for every docking back-
end. In the case of AutoDock Vina, GOLD, and rDock 
(Fig.  4a, c, and e), the docking scores learning curves 
fluctuate and sometimes exhibit sharp spikes, in con-
trast to the smooth optimizations observed for Hybrid 
and Glide (Fig.  4b and d). The difference in agent per-
formance is attributed to the stochasticity of AutoDock 
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Fig. 3 DockStream DEKOIS 2.0 benchmarking.26 Docking configurations used represent every combination possible between the docking 
backends: AutoDock Vina (ADV), GOLD, Glide, Hybrid, and rDock, and the ligand embedders: Corina, LigPrep, and RDKit. CTE is Corina with 
TautEnum and RDKit TE is RDKit with TautEnum. See Methods for parameters used. The pROC AUC of a docking configuration that is no better than 
random selection in distinguishing active and decoy ligands is 0.434. A pROC AUC greater than 0.434 denotes enrichment
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Fig. 4 REINVENT-DockStream agent reinforcement learning training progress for selected experiments: a AutoDock Vina with RDKit and TautEnum 
against MK2 (PDB ID: 3KC3), b Glide with LigPrep against COX2 (PDB ID: 1CX2), c GOLD with RDKit and TautEnum against HDAC2 (PDB ID: 3MAX), 
d Hybrid with LigPrep against RXRα (PDB ID: 2P1RT), and e rDock with RDKit and TautEnum against TS (PDB ID: 1I00) (see Additional file 1: Figs. 
S16–33 for training plots of all experiments). ‘Known Actives’ docking scores (fitness scores for GOLD) from the DEKOIS 2.0 dataset are shown.26 
Docking and QED score optimization and the number of SMILES found are shown. Each epoch proposes batch size (128) number of compounds. 
Lower docking scores for AutoDock Vina, Glide, Hybrid, and rDock, and higher fitness scores for GOLD are considered better. The direction of the 
docking score optimizations reflect this difference. ‘SMILES found’ refers to the cumulative number of unique compounds proposed that pass a total 
score threshold. If every epoch generates only unique, valid, and favourable compounds, the plot is linear
(See figure on next page.)
Vina, GOLD, and rDock where compounds proposed 
at select epochs can be notably worse while docking 
scores continue to improve, on average [33, 38, 41]. The 
sharp spikes correspond to the agent exploring chemi-
cal space as enforced by the DF and in which generated 
compounds fail to dock or dock poorly. While changing 
the docking parameters such as removing constraints or 
increasing sampling time can make docking more robust 
to these events, the momentary drop in performance 
did not hinder overall optimization across all docking 
backends. At the end of the 1000 epochs, the docking 
scores for all experiments converged to a point where 
the average score for the batch of compounds proposed 
by the agent are in the same range as the active ligands 
provided in the DEKOIS 2.0 dataset. Moreover, the top 
compounds (based on total score) display even more 
favourable docking scores, especially when S(x) uses a 
weighted geometric mean, necessitating every prop-
erty to be reasonably optimized. Thus, the top proposed 
compounds at the very least exhibit docking scores that 
are similar, if not better, than verified active ligands. The 
QED scores were also improved on average for every 
docking backend, ensuring proposed compounds are 
“drug-like” (Fig. 4). Similar to docking, momentary drops 
in QED optimization can be attributed to the stochastic-
ity of agent exploration. Other properties that were opti-
mized include the number of hydrogen bond donors and 
molecular weight (see Additional file  1: Figs. S16–33). 
The transformed scores for these properties across all 
docking backends and across all epochs ranged between 
0.77 and 0.99, as expected since the prior was trained 
on ChEMBL which curates “drug-like” compounds (see 
Additional file 1: Figs. S16–S3). While most compounds 
in ChEMBL are Lipinski compliant, the rules are simply a 
guideline and there are many drug molecules that violate 
it [56]. The rationale in enforcing the number of hydro-
gen bond donors (increased to 7) and molecular weight 
(200–575  Da) was that keeping proposed compounds 
within this expanded guideline should increase the like-
lihood of obtaining a successful first candidate molecule 
when domain knowledge is typically not well established. 
It follows that docking scores are generally more mean-
ingful amongst Lipinski compliant compounds, prevent-
ing molecules from being completely decorated with 
-OH groups or possessing excessive hydrophobicity that 
exploits the docking algorithm to achieve an artificially 
high docking score. Furthermore, the number of unique 
SMILES found exhibit almost a linear relationship for all 
docking backends (Fig.  4) indicating agent exploration. 
The exception was rDock which generated less favourable 
and unique compounds at the start of the REINVENT 
experiment (Fig.  4e) which is attributed to the agent 
exploring similar and unfavourable chemical space at the 
beginning of training. Importantly, agent training is dem-
onstrated as all properties including docking were still 
optimized over time. The percentage of valid SMILES for 
all experiments and across all epochs was between 90 and 
99% which was also expected as the prior was trained on 
ChEMBL (see Additional file  1: Figs. S17–33). The out-
come of the REINVENT-DockStream experiments are 
libraries of proposed compounds that are drug-like and 
exhibit docking scores similar or better than verified 
active ligands.
Agent exploration and exploitation
Compound diversity is exemplified in Fig.  5 which dis-
plays 3 out of the top 10 compounds (based on total 
score) of each REINVENT-DockStream experiment. 
In general, the top compounds were generated at later 
epochs and possess diverse scaffolds from sampling 
numerous local minima, effectively circumventing mode 
collapse [51]. Agent exploration is demonstrated by both 
the training plots which display gradual optimization of 
docking scores (Fig. 4) and the top sampled compounds 
(Fig.  5) which feature diverse scaffolds. Furthermore, 
agent perceived desirable scaffolds can be generated mul-
tiple times, as illustrated by GOLD and rDock (Fig.  5c 
and e). Interestingly, the top GOLD and rDock com-
pounds shown in Fig.  5c and e share subtle differences 
and vary only by 1 or 2 atoms. The scores achieved by 
these compounds were nearly identical and suggests the 
agent implicitly learns 3D structural information when 
docking is incorporated into the scoring function. This 
is further exemplified by the Glide docking experiments 
performed against cyclooxygenase 2 (COX2) which is a 
target for anti-inflammation (Fig.  5b) [60, 61]. The pro-
posed sulfonamide moiety (also observed ubiquitously 
in replicate experiments) is present in the approved 
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Fig. 4 (See legend on previous page.)
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Fig. 5 Selected top compounds generated from the experiments shown in Fig. 4. Epoch refers to the cycle in which they were observed, and 
corresponding docking scores (fitness scores for GOLD) are shown. a AutoDock Vina with RDKit and TautEnum against MK2 (PDB ID: 3KC3), b Glide 
with LigPrep against COX2 (PDB ID: 1CX2), c GOLD with RDKit and TautEnum against HDAC2 (PDB ID: 3MAX), d Hybrid with LigPrep against RXRα 
(PDB ID: 2P1T), and e. rDock with RDKit and TautEnum against TS (PDB ID: 1I00). ‘Known Actives’ docking scores (fitness scores for GOLD) from the 
DEKOIS 2.0 dataset are shown. [26]
drugs, Celecoxib and Valdecoxib, although the latter was 
discontinued due to cardiovascular toxicity [61]. The 
agent was initialized based on a random sampling of the 
ChEMBL dataset and therefore did not possess any pre-
conceived structural bias. The generation of sulfonamide 
containing compounds suggests agent structural aware-
ness capable of exploiting the shape and electrostatics of 
the binding cavity. Overall, the top compounds (based on 
total score) across all experiments contained compounds 
that optimized every component specified in the scor-
ing function. The general diversity observed for the top 
proposed compounds provide multiple solutions to the 
MPO problem and demonstrates the synergistic applica-
tion of agent exploration with a DF enforced.
Compounds generated at similar epochs can share the 
same scaffold, as exemplified by the GOLD (epochs 997 
and 968) and rDock (epochs 780 and 747) top selected 
compounds (Fig. 5c and e).
Intuitively, agent generated compounds from neigh-
bouring epochs are expected to share a greater similar-
ity than epochs further apart, as the agent is sampling 
from an area “close-by” in chemical space. Also, one 
would expect this trend to be more pronounced the more 
focused the agent gets over the course of the training. 
In order to quantify this behaviour, the average linkage 
similarity (Tanimoto) between every 5 epochs has been 
calculated (see “Methods” section for details) for every 
REINVENT-DockStream experiment (See Additional 
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Fig. 6 Average linkage similarity between epochs (Tanimoto) for every 5 epochs for REINVENT-DockStream using GOLD with RDKit and TautEnum 
against HDAC2 (PDB ID: 3MAX). a GOLD fitness score training plot (same as Fig. 4c). The vertical black line at around epoch 275 indicates the start 
of convergence whereby the GOLD fitness score begins to plateau. b GOLD Tanimoto matrix illustrating the Tanimoto similarities between batches 
of generated compounds across the entire 1000 epochs REINVENT-DockStream experiment (x-axis is on the scale of 5 epochs, e.g. epoch 10 and 
200 correspond to epoch 50 and 1000, respectively). The main diagonal is darker shaded, indicating notable intra-batch compound similarity. 
The overall matrix transitions from lighter (top left) to darker (bottom right) shaded areas. Cross-referencing with subplot a, neighbouring epochs 
display notably greater Tanimoto similarity, coinciding with GOLD fitness Score convergence. The results suggest the agent begins exploitation 
once a state of productivity is achieved (as measured by fitness score convergence). The overall transition of the matrix demonstrates agent 
exploration and exploitation is darker (indicating higher similarity) relative to surrounding epochs and gradually becomes even darker, which 
indicates increased intra-batch similarity as the agent increasingly focuses on regions in chemical space. Moreover, the transition between the 
lighter shaded top left corner to the darker shaded bottom right corner exemplifies balance between agent exploration and exploitation. By 
cross-referencing the REINVENT-DockStream training plot for GOLD docking (Fig. 6a), one can identify that the GOLD docking score begins to 
converge at around epoch 275. At around epoch 55 in Fig. 6b (corresponds to epoch 275), the Tanimoto matrix gradually becomes darker shaded, 
indicating increased Tanimoto similarity within the same batch and neighbouring epochs batches (Fig. 6b). The results demonstrate policy update, 
reaching a state of productivity and enforcing the agent to begin exploitation of chemical.
file  1: Figs. S35–51) [62] Fig.  6b shows the resulting 
Tanimoto matrix for the GOLD experiment displayed in 
Figs. 4c and 5c. Firstly, the main diagonal of the Tanimoto 
matrix.
space. Furthermore, even once exploitation begins, the 
Tanimoto similarities do not converge to 1. The agent 
continues to explore chemical space as necessitated by 
the DF applied. In addition, one can observe that the Tan-
imoto similarities corresponding to surrounding epochs 
is greater (on average), further supporting gradual and 
iterative policy update. The results show that REINVENT 
achieves both chemical space exploration and exploita-
tion and enforces sampling of numerous local minima.
Comparison of generated compounds to known actives 
and decoys
As an initial investigation into the quality of gener-
ated compounds, REINVENT-DockStream using Glide 
with LigPrep against COX2 was performed in triplicate 
and used as the model experiment to assess the simi-
larity of agent generated compounds to known actives 
and decoys. The top 150 compounds (based on total 
score) from each replicate were pooled and duplicates 
removed, resulting in 298/450 unique compounds, which 
amounts to about 33% overlap between the individual 
replicates. The Tanimoto similarities were calculated for 
each top generated compound compared to each known 
active (40 total) or decoy (1200 total), as provided in the 
DEKOIS 2.0 dataset, respectively. [26] The highest Tani-
moto similarities were kept, resulting in distributions 
describing the maximum resemblance of a top gener-
ated compound (based on total score) to a known active 
or known decoy (Fig.  7). The prior was trained on the 
ChEMBL dataset and contains 33/40 and 1/1200 of the 
known actives and known decoys, respectively. While no 
actives were recovered, it is evident that the agent gen-
erated compounds with notable structural similarity to 
known actives as measured by a Tanimoto similarity > 0.7 
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Fig. 7 Distributions of the highest Tanimoto similarities for the top compounds compared to known actives and decoys provided in the DEKOIS 
2.0 dataset [26]. REINVENT-DockStream using Glide with LigPrep against COX2 (PDB ID: 1CX2) was ran in triplicate. The top 150 compounds from 
each experiment were pooled and duplicates removed, resulting in 298 unique top compounds. Each of these compounds were compared to 
each active (40 total) or decoy (1200 total) and the highest Tanimoto similarity kept. a Highest Tanimoto similarity analysis for the COX2 actives. The 
most similar compound achieved a Tanimoto similarity of 0.937 compared to the ‘Known Active’. b Highest Tanimoto similarity analysis for the COX2 
decoys. The most similar compound achieved a Tanimoto similarity of 0.631 to the ‘Known Decoy’
(Fig.  7a). It follows from Fig.  6b that many of the top 
compounds contain the sulfonamide moiety which is 
present in the approved drugs, Celecoxib and Valdecoxib 
[60, 61]. The maximally similar generated compound dis-
plays a Tanimoto similarity of 0.937 and shares both the 
sulfonamide moiety and the cis-stilbene scaffold with its 
corresponding known active (Fig.  7a). In contrast, the 
highest Tanimoto similarity observed for the most simi-
lar decoy to a top generated compound is 0.631 (Fig. 7b). 
While the scaffold is shared, the vital sulfonamide moi-
ety is not present. Moreover, the decoy ligands set (1200 
total) is 30 × larger than the active ligands set (40 total). 
If the agent policy was not meaningfully updated dur-
ing the generative process, the likelihood of observing a 
high Tanimoto similarity (> 0.7) in the decoys set should 
be increased. Thus, the integration of DockStream with 
REINVENT facilitates agent convergence to relevant 
chemical space and the absence of actives recovered does 
not preclude the generated compounds from being true 
actives and potentially even more potent. Overall, the 
absence of Tanimoto similarities above 0.631 amongst 
the decoys and the presence of Tanimoto similarities > 0.7 
amongst the actives suggests the agent is biased towards 
generating compounds that are more likely to be true 
actives.
3D structural awareness
While generated compounds can satisfy the scoring func-
tion almost perfectly, their usefulness strongly depends 
on the plausibility of their binding poses, as commonly 
assessed in virtual screening campaigns. To further 
investigate agent 3D structural awareness, the predicted 
binding poses of one ligand from the top 10 compounds 
(based on total score) produced by the experiments 
shown in Fig.  4 were analyzed (Fig.  8). Docking against 
MK2, a serine and threonine kinase target for anti-
inflammation, was performed using AutoDock Vina 
with RDKit and TautEnum. Structure–activity relation-
ship (SAR) studies demonstrated interactions between 
the co-crystallized ligand and residues Lys 93 and Thr 
206 are vital for potency [63]. The generated ligand 
retains these interactions and is predicted to exploit an 
additional hydrogen bonding interaction with Asn 191 
(Fig.  8a). The overlap between the reference and gener-
ated ligand suggests the latter as a plausible binding pose 
and represents a solution obtained using only free soft-
ware. Similarly, docking against COX2, a target for anti-
inflammation, was performed using Glide with LigPrep 
[60, 61]. SAR studies demonstrated the cis-stilbene motif 
and the phenylsulfonamide moiety are paramount for 
potency and selectivity over COX1, respectively. The lat-
ter is attributed to the smaller residue Val 523 in COX2 
in place of Ile 523 in COX1 facilitating easier access to 
the binding cavity [61]. The generated ligand retains the 
cis-stilbene backbone and the sulfonamide group, which 
is predicted to form hydrogen bond interactions with 
Leu 352, Ser 353, His 90, and Arg 513 (Fig.  8b). Nota-
bly, approved drugs against COX2 include Celecoxib 
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Fig. 8 Binding poses of generated compounds from selected experiments shown in Fig. 5 (see Additional file 1: Fig. S34 for all other experiments). 
a AutoDock Vina with RDKit and TautEnum against MK2 (PDB ID: 3KC3) b Glide with LigPrep against COX2 (PDB ID: 1CX2). “Reference” (gray) is the 
co-crystallized ligand and its interactions are shown as yellow dotted lines. “Generated” (green) is a selected compound from the top 10 compounds 
(based on total score) and its interactions are shown as turquoise dotted lines. Note: The sulfonamide moiety of the reference ligand, as provided in 
the crystal structure, should be rotated 180° such that the  NH2 hydrogens are pointed towards Leu 352 and Ser 353 rather than His 90 and Arg 513
and Valdecoxib which also contain the aforementioned 
structural features [61]. Crucially, the predicted binding 
pose for the de novo compound overlaps significantly 
with the co-crystallized ligand which is another selective 
COX2 inhibitor (SC-558), yielding greater confidence in 
its plausibility [60, 61]. The same analysis was conducted 
for the GOLD, Hybrid, and rDock experiments shown in 
Fig.  4. Docking against HDAC2, a histone deacetylase, 
was performed using GOLD with RDKit and TautEnum. 
SAR studies demonstrated the interaction with zinc and 
large bulky groups that extend deep into the ‘foot pocket’ 
are important for potency [64]. The generated ligands 
retain interactions with zinc and Gly 154 and overlap 
significantly with the co-crystallized ligand (see Addi-
tional file  1: Fig. S34i). In another experiment, we used 
Hybrid with LigPrep as a docking component to design 
compounds against retinoid X receptor alpha (RXRα), 
a vital component in nuclear receptors. The co-crystal-
lized ligand, CD3254 is an agonist and binds by modu-
lating the H12 helix into its ‘active’ conformation [65]. 
While the generated ligands do not retain these interac-
tions, their predicted binding poses are not in conflict 
with the required conformation of the H12 helix. On the 
other hand, a common interaction with Arg 316 which 
is formed by endogenous ligands such as 9-cis retinoic 
acid is retained by the generated ligands, although there 
is some precedent that its role to facilitate binding is not 
essential (see Additional file  1: Fig. S34k) [66]. Finally, 
docking against thymidylate synthase (TS), responsible 
for converting deoxyuridine monophosphate (dUMP) 
into deoxythymidine monophosphate (dTMP) was per-
formed using rDock with RDKit and TautEnum. The co-
crystallized ligand is Tomudex, an approved drug which 
interacts with dUMP via stacking interactions and the 
quinazoline ring forms the only hydrogen bond interac-
tions with Asp 218 and Gly 222 (see Additional file 1: Fig. 
S34o) which are retained by the generated ligands [67]. 
Overall, all REINVENT-DockStream experiments gen-
erated compounds that retain vital interactions and dis-
play excellent agreement with reference ligand binding 
poses, suggesting the agent learns implicitly 3D struc-
tural information (see Additional file  1: Table  S1 for all 
REINVENT-DockStream experiments and Fig. S34 for all 
selected binding poses).
Steering chemical space exploration to diverse local 
minima
The diversity and convergence of REINVENT-Dock-
Stream was investigated on a larger scale. Uniform 
Manifold Approximation and Projection (UMAP) was 
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Fig. 9 Uniform Manifold Approximation and Projection (UMAP) dimensionality reduction to illustrate chemical space coverage of triplicate Glide 
with LigPrep REINVENT-DockStream experiments against COX2 (PDB ID: 1CX2). Morgan fingerprints (radius 3, 1024 bits) for the top 1000 and 3000 
compounds (based on total score) for each replicate were extracted to illustrate topology features. Chemical space coverage is stochastic in nature 
and thus, multiple replicates are used in practice to optimize output diversity. “Random Sampling” refers to sampling compounds from the prior 
generative model whose policy has not been focused on any task. a Top 1000 (based on total score) compounds generated by the agent in each 
triplicate experiment b Top 3000 (based on total score) compounds generated by the agent in each triplicate experiment. Some overlap between 
replicate experiments is observed, demonstrating steering of chemical space exploration to similar local minima
used as a dimensionality reduction technique to visual-
ize the span of chemical space occupied by generated 
compounds compared to random sampling by the prior 
which has not been focused on any task (Fig.  9) [68]. 
REINVENT using Glide with LigPrep against COX2 
was performed in triplicate and visualized by reduc-
ing the Morgan fingerprints (radius 3, 1024 bits) of the 
top 1000 and 3000 proposed compounds to 2D [69]. It 
is evident that the random sampling of molecules from 
the ChEMBL dataset occupies a single cluster (Fig. 9). In 
contrast, agent perceived desirable compounds occupy 
a much more diverse chemical space, forming numer-
ous clusters representing different local minima. Impor-
tantly, this necessitates the compounds to be diverse, 
further supporting the application of a DF in molecular 
generation and demonstrating balance between agent 
exploration and exploitation. Interestingly, the chemi-
cal space spanned by the top compounds from the Glide 
REINVENT triplicate experiments overlap significantly. 
The agent is initialized at a random chemical space and 
is iteratively updated to satisfy the pre-defined scoring 
function. The UMAP results suggest that irrespective of 
the chemical space starting point and the stochasticity 
associated with Glide and the conditional probabilities 
of token sampling, iterative optimization can lead to con-
vergence. These results demonstrate steering of chemical 
space exploration via RL and suggest that while replicate 
experiments yield a more complete coverage of chemical 
space (deemed favourable by the agent), single experi-
ments may not drastically compromise agent exploration.
Discussion
In this work, we present DockStream, a molecular dock-
ing wrapper providing facile access to a collection of 
ligand embedders and docking backends. The capabilities 
of the platform are extended by the benchmarking and 
analysis workflow which automates molecular docking 
and post hoc analysis. The use of DockStream as a stand-
alone docking tool was demonstrated by reproducing and 
extending the DEKOIS 2.0 dataset with additional dock-
ing backends (Hybrid and rDock) and ligand embedders 
(Corina and RDKit). DockStream facilitates large-scale 
automation of molecular docking and supports various 
computational chemistry software suites. The supported 
analysis modes can enhance VS endeavours by expedit-
ing the identification of a suitable docking configuration. 
It was unsurprising that the DEKOIS 2.0 benchmarking 
demonstrated that docking can be particularly sensitive 
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to the receptor and docking parameters, whereby small 
modifications in the protocol can have an enormous 
impact on enrichment. DockStream also outputs the 
binding poses, providing a convenient intermediate for 
downstream computational experiments such as re-
scoring or more accurate methods to assess binding free 
energy. To this end, the extensive capabilities of Dock-
Stream ligand enumeration provides excellent compat-
ibility with the aforementioned techniques which often 
require numerous conformational representations [70].
The integration of DockStream with the de novo design 
platform, REINVENT, enhances its generative capabili-
ties beyond standard QSAR models which often suffer 
from limited domain applicability [11, 12]. In particular, 
one is often interested in focusing on either agent chemi-
cal space exploration or exploitation, which are both sup-
ported in REINVENT. While QSAR models can perform 
well in the latter scenario provided the predictive model 
was trained on similar compounds (often belonging to 
the same series), extrapolating to new chemical space will 
likely be inaccurate. Molecular docking is chemical space 
agnostic and provides a more generalized solution to 
incorporating structural information during the genera-
tive process. However, docking will greatly increase the 
computational costs relative to trained QSAR models, 
warranting consideration over the quality of compounds 
generated. To assess the performance of REINVENT-
DockStream, 15 different targets from the DEKOIS 2.0 
dataset along with their corresponding docking configu-
rations were selected [26]. We emphasize the choice of 
docking configurations that display enrichment and offer 
distinction between ‘good’ docking scores, providing an 
unambiguous endpoint for docking score optimization 
and increases the likelihood of generated compounds 
being true actives. We show that REINVENT-Dock-
Stream optimizes docking scores across all docking back-
ends while maintaining “drug-likeliness” as enforced by 
the QED score [57]. Furthermore, molecular weight was 
incorporated in the scoring function which helped cir-
cumvent artificially high docking scores displayed in 
relatively large molecules, owing to the sheer number of 
interactions possible. Large molecules may also be more 
prone to entropically driven binding, causing off-target 
effects [52]. Thus, generating compounds that conform 
to a reasonable size increases the overall quality of the 
results. Finally, the use of a diversity filter maintains agent 
exploration as demonstrated by the number of unique 
SMILES proposed [4].
In order to elucidate the balance between agent explo-
ration and exploitation in REINVENT-DockStream 
experiments, the average linkage similarity between 
epochs (Tanimoto) was calculated [62]. The results 
demonstrate increased intra-batch similarity relative 
to surrounding epochs, indicating agent sampling from 
similar chemical space within a given epoch. Moreover, 
as agent training proceeds, there is a clear transition to 
greater similarity values at later epochs, paralleling the 
transition from agent exploration to exploitation. To fur-
ther assess generated compounds from agent exploita-
tion, the generated top compounds (based on total score) 
were compared to known actives and known decoys 
as provided in the DEKOIS 2.0 dataset [26]. While the 
known actives were not recovered, the top compounds 
show a clear enrichment in the Tanimoto similarities over 
the known decoys. The results demonstrate the agent is 
steered to chemical space similar to that of experimen-
tally validated active compounds. Furthermore, the qual-
ity of generated compounds was analyzed by comparing 
their binding poses relative to known binders. We show 
that generated compounds retain vital interactions in 
the binding cavity and exploit new ones. Crucially, the 
binding poses overlap with known binders, increasing 
confidence in the prediction. Moreover, we show that 
3D structural information is implicitly incorporated 
during the generative process by exploiting structural 
motifs and moieties that conform to subtle changes in the 
binding cavity. Finally, the stochasticity of REINVENT-
DockStream was investigated by visualizing the chemical 
space spanned by the top generated molecules using Uni-
form Manifold Approximation and Projection (UMAP) 
as a dimensionality reduction technique [68]. Compared 
to random sampling, agent generated compounds form 
clusters over a diverse area and generally converge over 
replicate runs.
Further work will focus on expanding the capabilities 
of DockStream to address limitations in the reliability of 
docking scores. Currently, the output binding poses can 
only be triaged manually but provide an invaluable data-
base for further structure-based methods. In particular, 
negative image-based rescoring (R-NiB) has been shown 
to enhance enrichment in terms of activity [71]. Other 
possible enhancements include an explicit handling of 
ligand internal strain energy which is typically not well 
captured by docking algorithms. It has been shown that 
proper consideration can enhance docking enrichment 
and limit the number of false positives [72]. DockStream 
will receive continued support to ensure all supported 
backends are up to date, such as the integration of the 
recently reported AutoDock Vina 1.2.0 functionalities 
[73]. The DockStream codebase is provided at https:// 
github. com/ Molec ularAI/ DockS tream. An additional 
repository with executable tutorials on supported fea-
tures and workflows is provided at https:// github. com/ 
Molec ularAI/ DockS tream Commu nity.
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Conclusions
Generative models have been successfully applied to de 
novo design, generating compounds which satisfy a wide 
variety of properties. The integration of QSAR models 
aim to incorporate structural information in the gen-
erative process. However, these models can suffer from 
limited applicability domains. Consequently, extrapolat-
ing out of sample can be unreliable and potentially mis-
inform the generative agent especially when chemical 
space exploration is desired. We built upon recent work 
that incorporates molecular docking in place of QSAR 
models for better generalization. DockStream is pre-
sented as a molecular docking wrapper which provides 
access to a collection of ligand embedders and docking 
backends. The use of DockStream as a stand-alone dock-
ing tool was demonstrated by large-scale docking efforts 
for a wide variety of targets and showcasing the automa-
tion of docking execution and post hoc analysis via the 
benchmarking and analysis workflow. The results show 
that it is beneficial to integrate several ligand embed-
ders and docking backends in DockStream, so as to find 
a productive docking configuration for diverse end appli-
cations. The integration of DockStream with the recently 
published de novo design platform, REINVENT, demon-
strates docking score optimization across all supported 
docking backends. The generated compounds retain 
vital interactions in the binding cavity and exploit new 
interactions. Extensive agreement with binding poses of 
known binders increases the confidence of the generated 
compounds and demonstrates the value of using docking 
to implicitly inform the generative process of 3D struc-
tural information. DockStream has the potential to be 
especially impactful in REINVENT experiments aiming 
at exploring novel chemotypes by providing a chemi-
cal space agnostic component that helps the agent learn 




Receptor crystal structures were obtained from the Pro-
tein Data Bank (PDB) with corresponding PDB IDs as 
specified in the DEKOIS 2.0 dataset (except SIRT2 which 
used PDB ID 5Y0Z so as to provide a reference ligand) 
[26, 74]. The PDB structures were processed by remov-
ing redundant chains possessing duplicate ligands, co-
factors, and ions. All water molecules were also removed. 
The configurations for further processing depended on 
the docking backend to be used. For docking with Auto-
Dock Vina, Glide, or rDock, the Protein Preparation Wiz-
ard in Maestro (release 2019–4) was used [75, 76]. The 
PDB structures were pre-processed with default param-
eters, followed by PROPKA hydrogen bond network 
optimization at pH 7.4, and minimized using the OPSL3e 
force-field [77]. Alternatively, for docking with Hybrid or 
GOLD, PDBFixer (Conda package version 1.7) was used 
to remove heterogens and add missing heavy atoms and 
hydrogens [78]. All processed receptor structures were 
saved as PDB files and used as is for grid generation.
Receptor grid generation
Receptor grids were generated using the processed PDB 
structures and followed different docking specific con-
figurations. For AutoDock Vina, Open Babel (Conda 
package version 3.1.1) was used to convert the PDB file 
into PDBQT format and coordinates for the binding cav-
ity were defined using the reference ligand [79]. The grid 
box size was 15 X 15 X 15  Å. For Glide, the reference 
ligand was used to define the binding cavity in Recep-
tor Grid Generation in Maestro [80]. Default parameters 
were used, specifying a grid box size of 20 X 20 X 20 Å to 
generate the corresponding ZIP grid file. For GOLD, the 
BindingSiteFromLigand class in the Docking API (release 
2020.0.1 CSD) using the reference ligand with the dis-
tance parameter set to 10 Å was used to generate the grid 
[38, 81]. For Hybrid, the OEMakeReceptor method in the 
OEDocking API (release 3.0.8) using the reference ligand 
was used to generate the OEB grid [39]. For rDock, the 
rbcavity method (version 2013.1) using the reference 
ligand (in cases where an atom parsing error occurred, 
the reference ligand was first processed in the Protein 
Preparation Wizard) with radius set to 5 Å centered on 
each atom was used to generate the updated PRM grid 
file. The output from each of these configurations was 
used as is for docking.
Ligand preparation
The ligands SMILES for the actives and decoys sets were 
downloaded from the DEKOIS 2.0 web server [26]. The 
ligands were processed following different configurations 
depending on the ligand embedder used. For Corina 
with TautEnum (tool to enumerate tautomers and pro-
tonation states, version 2.0.0), default parameters were 
used [27–29, 54, 55]. For LigPrep, default parameters 
were used except for Epik, for which the target pH was 
set to 7.0 with a tolerated range of ± 2.0 [30]. The ligand 
energies were minimized using the OPSL3e force-field 
[77]. For RDKit (version 2020.09.3) with TautEnum, 
default parameters were used except for the number of 
maximum iterations, which was set to 600 (for Univer-
sal Force-Field, UFF) to ensure convergence for all com-
pounds [82]. All prepared ligands were saved as SDF files 
and also stored internally in DockStream as RDKit mol-
ecules for subsequent docking.
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Docking
The entire DEKOIS 2.0 dataset was docked using Auto-
Dock Vina, Glide, GOLD, Hybrid, and rDock using 
ligands embedded by Corina with TautEnum, LigPrep, 
and RDKit with TautEnum, resulting in 15 docking runs 
per protein target and a total of 1215 docking experi-
ments amounting to over 1,506,600 ligands docked [27–
30, 33–38, 40, 41, 54, 55]. Default docking parameters 
were used unless specified as follows: AutoDock Vina and 
rDock were configured to return 2 and 12 poses, respec-
tively. GOLD used the ChemPLP scoring function and 
was allowed up to 10 docking attempts with autoscale 
set to 0.25. Generally, the active and decoy ligands sets 
were comprised of 40 and 1200 ligands, respectively 
(39 actives and 1170 decoys for SARS-HCoV and 1199 
decoys for TS). Only the best tautomer or ionization state 
(if applicable) per ligand as assessed by its docking score 
was kept. In some cases, ligands failed to be embed-
ded or docked, which are attributed to ligand embedder 
failure or the docking backends’ inability to find a good 
pose. In addition, AutoDock Vina and GOLD failed to 
dock all ligands for 23/81 targets (ACE, ACE2, ADAM17, 
COX1, COX2, CYP2A6, EPHB4, FXA, HDAC2, HDAC8, 
HIV1PR, HIV1RT, KIF11, MMP2, NA, PDE4B, PDE5, 
PNP, QPCT, SARS-HCoV, SIRT2, Thrombin, and TK) 
and 4/81 targets (11betaHSD1, ALR2, HIV1PR, and 
INHA), respectively. In the original DEKOIS 2.0 work, 
this was resolved via manual expansion of the binding 
cavity which was not explored in this work [26].
Average linkage similarity (Tanimoto)
The average linkage similarity between epochs (Tani-
moto) was calculated for each REINVENT-DockStream 
experiment for every 5 epochs instead of every epoch to 
reduce the computational time while maintaining good 
interpretability. The average linkage similarity, L, is given 
by Eq. 5 [62]:
where  e1 and  e2 are epochs 1 and 2, respectively,  N1 
and  N2 are the number of molecules in epochs 1 and 2, 
respectively, and T is the Tanimoto similarity between 
molecules, denoted x . The result of Eq. 5 is a 200 × 200 
heatmap (as the average linkage similarity was calculated 
for every 5 epochs) for every REINVENT-DockStream 
experiment (see Additional file 1: Figs. S35–51).
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